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Dr Ali AbuRahma (Charleston, WV). This is a very interest-
ing presentation because we always hear about renal function
improvement after renal stenting, but not specifically about
parenchymal preservation. I may have missed this in your pre-
sentation, but did you notice any correlation between preoper-
ative serum creatinine and improvement after renal stenting (eg,
creatinine of 2.5 vs 1.5 to 2.0 and so forth)? I am asking this
question because a couple of years ago we analyzed the results of
196 renal stents done at our institution, and we found that
serum creatinine of 2.0 was predictive of stabilization or im-
provement of renal function. If it was below 2.0, it did not make
a difference at all.
Dr Mark Davies. We did not look at serum creatinine. The
literature now is moving toward using estimated glomerular filtra-
tion rate as a more appropriate marker of renal function. If patients
had an estimated glomerular filtration rate of less than 30, there
was a significant correlation with subsequent parenchymal loss.
Dr Joseph Schneider (Winfield, Ill). Was I correct to see in
your slide that no parenchymal loss was associated with a higher
rate of hypertension?
Dr Davies. Correct. The patients who had parenchymal losscontralateral disease. Hypertension did not fall out as a predictor of
parenchymal loss.
Dr Richard Cambria (Boston, Mass). You’ve described what
are likely predictable changes after the intervention that corre-
late with clinically relevant outcomes, but how about for clinical
decision-making–your data beforehand, do you have renal resistive
indices pretreatment on all your patients, and was that examined,
for example, with outcome? So in terms of decision-making, I
think we would like to know more about the pretreatment param-
eters that might relate to clinical responses.
DrDavies. An estimated glomerular filtration rate of less than
30, resistive index 0.8, and worst nephrosclerosis grade were
linked to subsequent parenchymal loss. Parenchymal loss is linked
to renal-related morbidity and decreased survival.
Dr Robert Cambria (Bangor, Me). Your data on the con-
tralateral kidney went by quite quickly and I didn’t really see it. I
wonder if you could compare for us the changes you saw in stented
kidneys versus nonstented kidneys, and was there any effect of the
stent? Did nonstented kidneys lose parenchyma faster than stented
kidneys?
Dr Davis. We did not include that data in the study, but the
contralateral kidneys were smaller than the ipsilateral kidneys at the
beginning of the study.
